Lung Cancer Therapy Using Naturally Occurring Products and Nano-technology


  • SYED SAIF IMAM IMAM Department of Pharmaceutical Sciences HIMT College of Pharmacy,


Theaflavins, Quercetin, Arctigenin, EGCG, Curcumin, Cinnamaldehyde, Lung Cancer, Nano-technology.


Lung Cancer is a severe type of cancer with highest mortality rate among all cancers. Natural products such as Theaflavins, Quercetin, Arctigenin, EGCG, Curcumin and Cinnamaldehyde are quite capable anti-inflammatory and anti-cancerous agents which are able to suppress ERK-MAPK, JAK-STAT, p38, AMPK, PI3K/Akt,MAPK, mTOR, STAT3, and wnt/β-catenin signal transduction pathways. These APIs inhibits the inflammatory and proliferator enzymes such as COX-2, caspase-3, MMP-9, MMP-2, NF-κB, p53, Bcl-xL, Bcl-2, Mcl-1, miR-210, cyclin D1, iNOS, IL-1β, TNF-α, IFN-γ, IL-6, IL-1α. All the above properties clearly show the anti-cancerous potential, but the problems arise because of their instability at gastro-intestinal tract pH. All the compounds either degrade at gastric pH or losses their cancerous potential. New generation nano-particles such as transferosomes are quite stable at 7.4 pH and it efficacy and drug entrapment potential are better than other conventional nano-particle systems. If these APIs are added inside the nano-vesicular structure of transferosomes and then loaded in pMDI canisters such as fluorocarbon polymerization (FCP) plasma coated canisters with a better propellant such as HFA-134a and delivered with the help of spacers can cure lungs cancer economically, efficiently with minimal side effects and it also ensures that the cancer will not reoccur.



Kang SM, Sung HJ, Ahn JM, Park JY, Lee SY, Park CS, Cho JY. The Haptoglobin β chain as a supportive biomarker for human lung cancers. MolBiosyst. 2011; 7: 1167-1175.

Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell.Cell Press. 2002 Feb;1(1):49-52.

Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. Cancer Metastasis Rev. 2003 Mar;22(1):39-46.

Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. Cancer Metastasis Rev. 2003 Mar;22(1):39-46.

Kumar V, Abbas AK, Fausto N, Robbins SL, Cotran RS. Robbins and Cotran pathologic basis of disease. Philadelphia, Elsevier Saunders. 2005.

David RG, Peter SH, Martin LS, Primo NL, Fred RH. Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics. Clin Cancer Res. 2015 May 15; 21(10): 2236–2243.

Gregory PK, Wallace A, Paul B, Hossein B, Laura QMC, Robert JD, Leena Gandhi, Apar KPG, Ramaswamy G, John CG, James H, Rebecca SH, Leora H, Thierry J, Marianna K, Billy WL, Robert EM, Cesar AM, Harvey BN, Janis O’M, Jyoti DP, Neal R, Charles MR, Charles CW, Kristina G, Miranda H. Small Cell Lung Cancer Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2013 Jan 1; 11(1): 78–98.

Kartikeya R, Abdul HS, Uroosa I, Prateek P, Tahir K, Dany ES. An Unusually Aggressive Large Cell Carcinoma of the Lung: Undiagnosed until Autopsy. Cureus. 2018 Feb;10(2).

Lu G, Liao J, Yang G, Reuhl KR, Hao X, Yang CS. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. 2006; 66: 11494–11501.

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006 Sep;296(10):1255-65.

Granja A, Pinheiro M, Reis S. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy. Nutrients. 2016 May 20;8(5):307.

Imam SS. The future of non-invasive ways to treat cancer. Int J Pharm Sci & Res 2021; 12(8): 4684-96. doi: 10.13040/IJPSR.0975- 8232.12(8).4684-96.

Yamada S, Tsukamoto S, Huang Y. Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells. Scientific reports. 2016; 6.

Shawn AM, Patrick B, David TC, Rebecca LB, Joshua JS, Jennifer LC, Briana JW, James AC. The Green Tea Polyphenol, EGCG, Potentiates the Anti-Proliferative Activity of c-Met and EGFR Inhibitors in Non-Small Cell Lung Cancer Cells. Clin Cancer Res. 2009 Aug; 15(15): 4885–4894.

Xiaobo Z, Kyung-WM, Jay W, Seung J. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate. J Cancer Res ClinOncol. 2012 Dec; 138(12): 2051–2060.

Weidong L, Shakir MS, Matthew RY, Guohong C, Baojin H. Targeting AMPK for cancer prevention and treatment. Oncotarget. 2015 Apr; 6(10): 7365–7378.

Zhang L, Xie J, Gan R, Wu Z, Luo H, Chen X, Lu Y, Wu L, Zheng D. Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082. J Cancer. 2019; 10(26):6543-6556.

O’Neill EJ, Termini D, Albano A, Tsiani E. Anti-Cancer Properties of Theaflavins. Molecules. 2021;26:987.

Imam SS, Imam ST, Mdwasifathar, Kumar R, Ammar MY. Interaction Between Ace 2 And Sars-Cov2, And Use Of EGCG And Theaflavin To Treat Covid 19 In Initial Phases. International Journal of Current Pharmaceutical Research. 2022 Mar; 14(2):5-10.

Ali I, Masood SB, Hang X, Muhammad I, Abdur R, Mohammad SM, Mohamed FR. Inhibitory effect of black tea (Camellia sinensis) theaflavins and thearubigins against HCT 116 colon cancer cells and HT 460 lung cancer cells. Journal of food biochemistry. 2019 Mar.

Park SK, Dahmer MK, Quasney MW. MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes. Cell Physiol Biochem. 2012;30(2):334-46.

Shalini S, Dorstyn L, Dawar S, Kumar S. Old, new and emerging functions of caspases. Cell Death Differ. 2015 Apr; 22(4): 526–539.

Jianping S, Qingyan M, Yongyuan L. Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma. Onco Targets Ther. 2016; 9: 4265–4275.

Aggarwal BB, Yuan W, Li S, Gupta SC. Curcumin‐free turmeric exhibits anti‐inflammatory and anticancer activities: Identification of novel components of turmeric. Molecular nutrition & food research. 2013 Sep;57(9):1529-42.

Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular cancer. 2011 Dec;10(1):1-9.

Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 1999 Mar 1;20(3):445-51

Rao CV. Regulation of COX and LOX by curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. 2007:213-26.

Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda O, Mita S, Setoguchi T, Ogawa M. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer. 2002 Sep 15;95(6):1206-14.

Panaro MA, Corrado A, Benameur T, Paolo CF, Cici D, Porro C. The emerging role of curcumin in the modulation of TLR-4 signaling pathway: focus on neuroprotective and anti-rheumatic properties. International journal of molecular sciences. 2020 Jan;21(7):2299.

Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, Miller AH. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3, 5-Bis (2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. International immunopharmacology. 2012 Feb 1;12(2):368-77.

Rao PV. Gan SH. Cinnamon: a multifaceted medicinal plant. Evidence-Based Complementary and Alternative Medicine. 2014.

Soufli I. Toumi R. Rafa H. Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World journal of gastrointestinal pharmacology and therapeutics. 2016; 7(3):353.

Chao LK. Hua KF. Hsu HY. Cheng SS. Lin IF. Chen CJ. Chen ST. Chang ST. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food and Chemical Toxicology. 2008; 46(1):220-31.

Kim NY. Trinh NT. Ahn SG. Kim SA. Cinnamaldehyde protects against oxidative stress and inhibits the TNF α induced inflammatory response in human umbilical vein endothelial cells. International journal of molecular medicine. 2020; 46(1):449-457.

Pannee C. Chandhanee I. Wacharee L. Antiinflammatory effects of essential oil from the leaves of Cinnamomum cassia and cinnamaldehyde on lipopolysaccharide-stimulated J774A. 1 cells. Journal of advanced pharmaceutical technology & research. 2014; 5(4):164.

Maalik A. Khan FA. Mumtaz A. Mehmood A. Azhar S. Atif M. Karim S. Altaf Y. Tariq I. Pharmacological applications of quercetin and its derivatives: a short review. Tropical Journal of Pharmaceutical Research. 2014; 13(9):1561-1566.

Oh WJ. Endale M. Park SC. Cho JY. Rhee MH. Dual roles of quercetin in platelets: phosphoinositide-3-kinase and MAP kinases inhibition, and cAMP-dependent vasodilator-stimulated phosphoprotein stimulation. Evidence-Based Complementary and Alternative Medicine. 2012.

Bureau G. Longpré F. Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. Journal of neuroscience research. 2008; 86(2):403-410.

Xiao X. Shi D. Liu L. Wang J. Xie X. Kang T. Deng W. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One. 2011; 6(8):e22934. doi: 10.1371/journal.pone.0022934.

Endale M. Park SC. Kim S. Kim SH. Yang Y. Cho JY. Rhee MH. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology. 2013; 218(12):1452-67. doi: 10.1016/j.imbio.2013.04.019.

Yang D. Liu X. Liu M. Chi H. Liu J. Han H. Protective effects of quercetin and taraxasterol against H2O2‑induced human umbilical vein endothelial cell injury in vitro. Experimental and therapeutic medicine. 2015; 10(4):1253-60.

Yin Q. Wang L. Yu H. Chen D. Zhu W. Sun C. Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway. Frontiers in Pharmacology. 2021: 2350.

Zhao F, Wang L, Liu K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. Journal of ethnopharmacology. 2009 Apr 21;122(3):457-62.

Lou C, Zhu Z, Zhao Y, Zhu R, Zhao H. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells. Oncology reports. 2017 Jan 1;37(1):179-84.

Koundouros N, Poulogiannis G. Phosphoinositide 3-kinase/Akt signaling and redox metabolism in cancer. Frontiers in oncology. 2018 May 15;8:160.

Sun Y, Tan YJ, Lu ZZ, Li BB, Sun CH, Li T, Zhao LL, Liu Z, Zhang GM, Yao JC, Li J. Arctigenin inhibits liver cancer tumorigenesis by inhibiting gankyrin expression via C/EBPα and PPARα. Frontiers in Pharmacology. 2018 Mar 27;9:268.

Maxwell T, Lee KS, Kim S, Nam KS. Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells. International journal of oncology. 2018 Apr 1;52(4):1339-49.

Imam SS, Agarwal S. A Pragmatic Approach To Treat Lung Cancer Through Loading Theaflavin -3,3’-Digallate And Epigallocatechin Gallate In Spanlastic. Asian J Pharm Clin Res. 2021 Nov 7; 14(11): 1-8.

Modi CD, Bharadia PD. Transfersomes: new dominants for transdermal drug delivery. Am J Pharm Tech Res. 2012;2(3):71-91.



How to Cite

IMAM, S. S. I. (2022). Lung Cancer Therapy Using Naturally Occurring Products and Nano-technology. Innovare Journal of Medical Sciences, 10(4). Retrieved from



Review Article(s)